For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Kyverna Therapeutics Inc (NASDAQ: KYTX) closed at $4.00 in the last session, up 3.36% from day before closing price of $3.87. In other words, the price has increased by $3.36 from its previous closing price. On the day, 1.4 million shares were traded. KYTX stock price reached its highest trading level at $4.09 during the session, while it also had its lowest trading level at $3.8.
Ratios:
We take a closer look at KYTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 10, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On October 09, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
On July 03, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $8.H.C. Wainwright initiated its Neutral rating on July 03, 2024, with a $8 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 12 ’24 when Vida Ventures, LLC bought 253,136 shares for $22.00 per share. The transaction valued at 5,568,992 led to the insider holds 252,553 shares of the business.
Bain Capital Life Sciences Inv bought 450,000 shares of KYTX for $9,900,000 on Feb 12 ’24. The 10% Owner now owns 3,163,868 shares after completing the transaction at $22.00 per share. On Feb 12 ’24, another insider, GILEAD SCIENCES, INC., who serves as the 10% Owner of the company, bought 910,000 shares for $22.00 each. As a result, the insider paid 20,020,000 and bolstered with 4,126,119 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYTX now has a Market Capitalization of 172686400 and an Enterprise Value of -139781648.
Stock Price History:
Over the past 52 weeks, KYTX has reached a high of $35.06, while it has fallen to a 52-week low of $3.62. The 50-Day Moving Average of the stock is -18.89%, while the 200-Day Moving Average is calculated to be -62.70%.
Shares Statistics:
According to the various share statistics, KYTX traded on average about 360.51K shares per day over the past 3-months and 452690 shares per day over the past 10 days. A total of 43.17M shares are outstanding, with a floating share count of 18.72M. Insiders hold about 56.65% of the company’s shares, while institutions hold 31.26% stake in the company. Shares short for KYTX as of 1732838400 were 2103959 with a Short Ratio of 5.84, compared to 1730332800 on 2412408. Therefore, it implies a Short% of Shares Outstanding of 2103959 and a Short% of Float of 6.34.
